Scott J. Charles
2017
In 2017, Scott J. Charles earned a total compensation of $1.5M as Former Chief Financial Officer at Aralez Pharmaceuticals, a 32% decrease compared to previous year.
Compensation breakdown
| Option Awards | $86,859 |
|---|---|
| Salary | $375,667 |
| Stock Awards | $433,565 |
| Other | $601,000 |
| Total | $1,497,091 |
Charles received $601K in other compensation, accounting for 40% of the total pay in 2017.
Charles also received $86.9K in option awards, $375.7K in salary and $433.6K in stock awards.
Rankings
In 2017, Scott J. Charles' compensation ranked 6,995th out of 14,666 executives tracked by ExecPay. In other words, Charles earned more than 52.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,995 out of 14,666 | 52nd |
Division Manufacturing | 2,595 out of 5,772 | 55th |
Major group Chemicals And Allied Products | 843 out of 2,075 | 59th |
Industry group Drugs | 656 out of 1,731 | 62nd |
Industry Pharmaceutical Preparations | 515 out of 1,333 | 61st |
Source: SEC filing on May 18, 2018.
Charles' colleagues
We found five more compensation records of executives who worked with Scott J. Charles at Aralez Pharmaceuticals in 2017.
2017
Adrian Adams
Aralez Pharmaceuticals
Chief Executive Officer
2017
Andrew Koven
Aralez Pharmaceuticals
President and Chief Business Officer
2017
James Tursi
Aralez Pharmaceuticals
Chief Medical Officer
2017
Mark Glickman
Aralez Pharmaceuticals
Former Chief Commercial Officer
2017
Michael Kaseta
Aralez Pharmaceuticals